全文获取类型
收费全文 | 6976篇 |
免费 | 461篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 43篇 |
儿科学 | 105篇 |
妇产科学 | 114篇 |
基础医学 | 965篇 |
口腔科学 | 185篇 |
临床医学 | 783篇 |
内科学 | 1578篇 |
皮肤病学 | 92篇 |
神经病学 | 764篇 |
特种医学 | 272篇 |
外科学 | 1147篇 |
综合类 | 51篇 |
一般理论 | 3篇 |
预防医学 | 448篇 |
眼科学 | 119篇 |
药学 | 412篇 |
中国医学 | 7篇 |
肿瘤学 | 371篇 |
出版年
2023年 | 34篇 |
2022年 | 77篇 |
2021年 | 182篇 |
2020年 | 135篇 |
2019年 | 155篇 |
2018年 | 192篇 |
2017年 | 172篇 |
2016年 | 158篇 |
2015年 | 191篇 |
2014年 | 260篇 |
2013年 | 369篇 |
2012年 | 578篇 |
2011年 | 607篇 |
2010年 | 336篇 |
2009年 | 316篇 |
2008年 | 489篇 |
2007年 | 502篇 |
2006年 | 439篇 |
2005年 | 446篇 |
2004年 | 404篇 |
2003年 | 349篇 |
2002年 | 292篇 |
2001年 | 51篇 |
2000年 | 53篇 |
1999年 | 70篇 |
1998年 | 49篇 |
1997年 | 33篇 |
1996年 | 34篇 |
1995年 | 35篇 |
1994年 | 21篇 |
1993年 | 23篇 |
1992年 | 38篇 |
1991年 | 31篇 |
1990年 | 32篇 |
1989年 | 20篇 |
1988年 | 16篇 |
1987年 | 24篇 |
1986年 | 19篇 |
1985年 | 18篇 |
1984年 | 17篇 |
1983年 | 11篇 |
1981年 | 9篇 |
1979年 | 23篇 |
1978年 | 15篇 |
1975年 | 16篇 |
1974年 | 12篇 |
1973年 | 14篇 |
1969年 | 15篇 |
1968年 | 13篇 |
1967年 | 9篇 |
排序方式: 共有7459条查询结果,搜索用时 31 毫秒
101.
102.
Paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome are a spectrum of acquired marrow failure, having a common pathologic thread of both immune dysregulation and the development of abnormal hematopoiesis. Allogeneic hematopoietic cell transplantation plays a critical role in the treatment of these disorders and, for many patients, is the only treatment modality with demonstrated curative potential. In recent years, there have been many breakthroughs in the understanding of the pathogenesis of these uncommon disorders. The subsequent advances in non-transplant therapies, along with concurrent improvement in outcomes after hematopoietic cell transplantation, necessitate continual appraisal of the indications, timing, and approaches to transplantation for acquired marrow failure syndromes. We review here contemporary and critical new findings driving current treatment decisions. 相似文献
103.
104.
K Michielsen R Beauclair W Delva K Roelens R Van Rossem M Temmerman 《BMC public health》2012,12(1):729
ABSTRACT: BACKGROUND: While the HIV epidemic is levelling off in sub-Saharan Africa, it remains at an unacceptably high level. Young people aged 15-24 years remain particularly vulnerable, resulting in a regional HIV prevalence of 1.4% in young men and 3.3% in young women. This study assesses the effectiveness of a peer-led HIV prevention intervention in secondary schools in Rwanda on young people's sexual behavior, HIV knowledge and attitudes. METHODS: In a non-randomized longitudinal controlled trial, fourteen schools were selected in two neighboring districts: Bugesera (intervention) and Rwamagana (control). Students (n = 1950) in eight intervention and six control schools participated in three surveys (baseline, six and twelve months in the intervention). Analysis was done using linear and logistic regression using generalized estimation equations adjusted for propensity score. RESULTS: The overall retention rate was 72%. Time trends in sexual risk behavior (being sexually active, sex in last six months, condom use at last sex) were not significantly different in students from intervention and control schools, nor was the intervention associated with increased knowledge, perceived severity or perceived susceptibility. It did significantly reduce reported stigma. CONCLUSIONS: Analyzing this and other interventions, we identified several reasons for the observed limited effectiveness of peer education: 1) intervention activities (spreading information) are not tuned to objectives (changing behavior); 2) young people prefer receiving HIV information from other sources than peers; 3) outcome indicators are not adequate and the context of the relationship in which sex occurs. Effectiveness of peer education may increase through integration in holistic interventions and redefining peer educators' role as focal points for sensitization and referral to experts and services. Finally, we argue that a narrow focus on sexual risks will never significantly turn the tide. 相似文献
105.
106.
Combined anticoagulant and antiselectin treatments prevent lethal intravascular coagulation
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Norman KE Cotter MJ Stewart JB Abbitt KB Ali M Wagner BE Wallace WA Forlow SB Hellewell PG 《Blood》2003,101(3):921-928
Widespread microvascular injury followed by vessel obstruction may lead to disseminated intravascular coagulation (DIC). We describe a murine model wherein leukocytes interacting with inflamed microvessels in vivo are activated by antibodies. Treatment of tumor necrosis factor alpha (TNF-alpha)-primed mice with anti-Ly-6G antibodies reproduced many of the features of septic or traumatic shock including microvessel obstruction and coagulation, severe vasculitis, respiratory difficulties, and vascular leakage. Mice lacking either E-selectin or P-selectin were protected from this reaction as were animals treated with a combination of either selectin-blocking antibodies and heparin or a selectin antagonist plus heparin. Combined blockade of leukocyte/platelet adhesion and coagulation may provide convincing protection in DIC. 相似文献
107.
van Pinxteren B Numans ME Lau J de Wit NJ Hungin AP Bonis PA 《Journal of general internal medicine》2003,18(9):755-763
OBJECTIVE: To investigate the efficacy of acid suppressant drugs in the empirical treatment of gastroesophageal reflux disease (GERD) and in the treatment of endoscopy-negative reflux disease (ENRD). DESIGN: medline, embase, and the Cochrane Controlled Trials Register were searched. Bibliographies were reviewed. SETTING: Studies were eligible that compared the short-term use of proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) with each other or with placebo in adults with GERD who were enrolled irrespective of endoscopic findings (empirical cases) or in whom endoscopy showed no signs of esophagitis (endoscopy-negative cases). MEASUREMENTS: Of 1,408 studies, only 13 could be included for meta-analysis. Data on 3,433 patients empirically treated for GERD and 2,520 patients treated for ENRD were extracted. The primary endpoint was relief of heartburn. MAIN RESULTS: In the empirical treatment of GERD, the summary relative risk (sRR) for symptom relief from H2RAs versus placebo was 0.77 (95% confidence interval [95% CI], 0.60 to 0.99). RR in the only placebo-controlled PPI trial was 0.35 (95% CI, 0.26 to 0.46). The sRR for standard dose PPIs versus H2RAs was 0.55 (95% CI, 0.44 to 0.68). In treatment of ENRD, both PPIs (sRR, 0.64; 95% CI, 0.52 to 0.79) and H2RAs (sRR, 0.78; 95% CI, 0.62 to 0.97) were superior to placebo, and PPIs were superior to H2RAs (sRR, 0.81; 95% CI, 0.70 to 0.95). CONCLUSIONS: Acid suppressant therapy (with a PPI or an H2RA) is more effective than placebo for short-term relief of heartburn in patients with persistent symptoms who are treated empirically for GERD and in those in whom esophagitis was excluded after endoscopy. The benefit of PPIs compared with H2RAs is more pronounced in patients treated empirically. 相似文献
108.
109.
Eddie?A.?James Joana?R.?F.?Abreu John?W.?McGinty Jared?M.?Odegard Yvonne?E.?Fillié Claire?N.?Hocter Slobodan?Culina Kristin?Ladell David?A.?Price Aimon?Alkanani Marynette?Rihanek Lisa?Fitzgerald-Miller Ania?Skowera Cate?Speake Peter?Gottlieb Howard?W.?Davidson F.?Susan?Wong Bart?Roep Roberto?Mallone 《Diabetologia》2018,61(3):658-670
Aims/hypothesis
Validated biomarkers are needed to monitor the effects of immune intervention in individuals with type 1 diabetes. Despite their importance, few options exist for monitoring antigen-specific T cells. Previous reports described a combinatorial approach that enables the simultaneous detection and quantification of multiple islet-specific CD8+ T cell populations. Here, we set out to evaluate the performance of a combinatorial HLA-A2 multimer assay in a multi-centre setting.Methods
The combinatorial HLA-A2 multimer assay was applied in five participating centres using centralised reagents and blinded replicate samples. In preliminary experiments, samples from healthy donors were analysed using recall antigen multimers. In subsequent experiments, samples from healthy donors and individuals with type 1 diabetes were analysed using beta cell antigen and recall antigen multimers.Results
The combinatorial assay was successfully implemented in each participating centre, with CVs between replicate samples that indicated good reproducibility for viral epitopes (mean %CV = 33.8). For beta cell epitopes, the assay was very effective in a single-centre setting (mean %CV = 18.4), but showed sixfold greater variability across multi-centre replicates (mean %CV = 119). In general, beta cell antigen-specific CD8+ T cells were detected more commonly in individuals with type 1 diabetes than in healthy donors. Furthermore, CD8+ T cells recognising HLA-A2-restricted insulin and glutamate decarboxylase epitopes were found to occur at higher frequencies in individuals with type 1 diabetes than in healthy donors.Conclusions/interpretation
Our results suggest that, although combinatorial multimer assays are challenging, they can be implemented in multiple laboratories, providing relevant T cell frequency measurements. Assay reproducibility was notably higher in the single-centre setting, suggesting that biomarker analysis of clinical trial samples would be most successful when assays are performed in a single laboratory. Technical improvements, including further standardisation of cytometry platforms, will likely be necessary to reduce assay variability in the multi-centre setting.110.